CompletedNCT02239094
Biological Markers of Lurasidone Response in Bipolar Depression
About this title
Biosignatures of Latuda for Bipolar Depression
Read the official source — NCT02239094Medication studyAges 18–60United StatesBipolarity
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- New YorkSee all locations and recruitment
Study information
Study start dateJanuary 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02239094
- Official title
Show the full official title
Identification of Biosignatures for Lurasidone (Latuda) Response in Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Lurasidone (Latuda).
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
